Curtis T Keith Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Curtis T Keith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Curtis T Keith. Curtis T Keith is Senior VP, Research in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
Latest Insider Trading Transactions of Curtis T Keith
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2007 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | A | 8.79 | 44,698 | 392,895 | 44,698 | |
| Jan 19 2007 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | A | 8.79 | 11,552 | 101,542 | 11,552 | |
| Aug 10 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | M | 0.87 | 1,767 | 1,536 | 29,792 | |
| Aug 10 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 7.00 | 1,767 | 12,369 | 67,857 | 69.6 K to 67.9 K (-2.54 %) |
| Aug 10 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Buy | M | 0.87 | 1,767 | 1,536 | 69,624 | 67.9 K to 69.6 K (+2.60 %) |
| Aug 09 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | M | 0.87 | 1,849 | 1,608 | 31,559 | |
| Aug 09 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | M | 0.87 | 3,020 | 2,626 | 33,408 | |
| Aug 09 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 7.00 | 1,849 | 12,943 | 67,857 | 69.7 K to 67.9 K (-2.65 %) |
| Aug 09 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Buy | M | 0.87 | 1,849 | 1,608 | 69,706 | 67.9 K to 69.7 K (+2.72 %) |
| Aug 09 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 7.00 | 3,020 | 21,140 | 67,857 | 70.9 K to 67.9 K (-4.26 %) |
| Aug 09 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Buy | M | 0.87 | 3,020 | 2,626 | 70,877 | 67.9 K to 70.9 K (+4.45 %) |
| Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | A | 8.35 | 15,234 | 127,204 | 15,234 | |
| Jul 14 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | A | 8.35 | 3,516 | 29,359 | 3,516 | |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | M | 0.87 | 7,500 | 6,521 | 30,714 | |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.91 | 750 | 6,683 | 67,857 | 68.6 K to 67.9 K (-1.09 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.89 | 750 | 6,668 | 68,607 | 69.4 K to 68.6 K (-1.08 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.87 | 750 | 6,653 | 69,357 | 70.1 K to 69.4 K (-1.07 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.84 | 750 | 6,630 | 70,107 | 70.9 K to 70.1 K (-1.06 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.81 | 750 | 6,608 | 70,857 | 71.6 K to 70.9 K (-1.05 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.79 | 750 | 6,593 | 71,607 | 72.4 K to 71.6 K (-1.04 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.76 | 750 | 6,570 | 72,357 | 73.1 K to 72.4 K (-1.03 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.48 | 1,500 | 12,720 | 73,107 | 74.6 K to 73.1 K (-2.01 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.42 | 750 | 6,315 | 74,607 | 75.4 K to 74.6 K (-1.00 %) |
| Jul 11 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Buy | M | 0.87 | 7,500 | 6,521 | 75,357 | 67.9 K to 75.4 K (+11.05 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Option Exercise | M | 0.87 | 7,500 | 6,521 | 38,214 | |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.11 | 750 | 6,833 | 67,857 | 68.6 K to 67.9 K (-1.09 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.06 | 750 | 6,795 | 68,607 | 69.4 K to 68.6 K (-1.08 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.99 | 750 | 6,743 | 69,357 | 70.1 K to 69.4 K (-1.07 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.15 | 750 | 6,863 | 70,107 | 70.9 K to 70.1 K (-1.06 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.10 | 750 | 6,825 | 70,857 | 71.6 K to 70.9 K (-1.05 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.09 | 750 | 6,818 | 71,607 | 72.4 K to 71.6 K (-1.04 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.06 | 750 | 6,795 | 72,357 | 73.1 K to 72.4 K (-1.03 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 9.05 | 1,500 | 13,575 | 73,107 | 74.6 K to 73.1 K (-2.01 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Sell | S | 8.57 | 750 | 6,428 | 74,607 | 75.4 K to 74.6 K (-1.00 %) |
| Jul 07 2006 | CRXX | EPIRUS Biopharmace ... | Keith Curtis T | Senior VP, Research | Buy | M | 0.87 | 7,500 | 6,521 | 75,357 | 67.9 K to 75.4 K (+11.05 %) |
Page: 1